Logo image of OPRX

OPTIMIZERX CORP (OPRX) Stock Fundamental Analysis

NASDAQ:OPRX - Nasdaq - US68401U2042 - Common Stock - Currency: USD

12.7  -0.58 (-4.37%)

After market: 12.7 0 (0%)

Fundamental Rating

5

Taking everything into account, OPRX scores 5 out of 10 in our fundamental rating. OPRX was compared to 36 industry peers in the Health Care Technology industry. While OPRX seems to be doing ok healthwise, there are quite some concerns on its profitability. OPRX is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OPRX was profitable.
OPRX had a positive operating cash flow in the past year.
OPRX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OPRX reported negative operating cash flow in multiple years.
OPRX Yearly Net Income VS EBIT VS OCF VS FCFOPRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

OPRX has a better Return On Assets (-9.18%) than 63.89% of its industry peers.
OPRX's Return On Equity of -13.25% is fine compared to the rest of the industry. OPRX outperforms 63.89% of its industry peers.
Industry RankSector Rank
ROA -9.18%
ROE -13.25%
ROIC N/A
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
OPRX Yearly ROA, ROE, ROICOPRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 64.13%, OPRX is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
In the last couple of years the Gross Margin of OPRX has remained more or less at the same level.
OPRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
OPRX Yearly Profit, Operating, Gross MarginsOPRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

OPRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPRX has been increased compared to 1 year ago.
OPRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OPRX has an improved debt to assets ratio.
OPRX Yearly Shares OutstandingOPRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OPRX Yearly Total Debt VS Total AssetsOPRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

OPRX has an Altman-Z score of 2.88. This is not the best score and indicates that OPRX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.88, OPRX is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
The Debt to FCF ratio of OPRX is 5.20, which is a neutral value as it means it would take OPRX, 5.20 years of fcf income to pay off all of its debts.
OPRX has a better Debt to FCF ratio (5.20) than 69.44% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that OPRX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, OPRX is in line with its industry, outperforming 47.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 5.2
Altman-Z 2.88
ROIC/WACCN/A
WACC11.66%
OPRX Yearly LT Debt VS Equity VS FCFOPRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 2.82 indicates that OPRX has no problem at all paying its short term obligations.
OPRX has a better Current ratio (2.82) than 66.67% of its industry peers.
OPRX has a Quick Ratio of 2.82. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
OPRX's Quick ratio of 2.82 is fine compared to the rest of the industry. OPRX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.82
OPRX Yearly Current Assets VS Current LiabilitesOPRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

9

3. Growth

3.1 Past

OPRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.09%, which is quite impressive.
Measured over the past years, OPRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 101.23% on average per year.
Looking at the last year, OPRX shows a very strong growth in Revenue. The Revenue has grown by 20.66%.
OPRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.22% yearly.
EPS 1Y (TTM)126.09%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%172.73%
Revenue 1Y (TTM)20.66%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%11.37%

3.2 Future

The Earnings Per Share is expected to grow by 43.29% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.62% on average over the next years. This is quite good.
EPS Next Y70.44%
EPS Next 2Y43.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.64%
Revenue Next 2Y12.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OPRX Yearly Revenue VS EstimatesOPRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
OPRX Yearly EPS VS EstimatesOPRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.42, the valuation of OPRX can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of OPRX indicates a rather cheap valuation: OPRX is cheaper than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, OPRX is valued at the same level.
A Price/Forward Earnings ratio of 18.74 indicates a rather expensive valuation of OPRX.
83.33% of the companies in the same industry are more expensive than OPRX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of OPRX to the average of the S&P500 Index (21.76), we can say OPRX is valued inline with the index average.
Industry RankSector Rank
PE 24.42
Fwd PE 18.74
OPRX Price Earnings VS Forward Price EarningsOPRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

OPRX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, OPRX is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 37.57
EV/EBITDA 248.19
OPRX Per share dataOPRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

OPRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OPRX's earnings are expected to grow with 43.29% in the coming years.
PEG (NY)0.35
PEG (5Y)0.24
EPS Next 2Y43.29%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OPRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTIMIZERX CORP

NASDAQ:OPRX (7/11/2025, 8:00:02 PM)

After market: 12.7 0 (0%)

12.7

-0.58 (-4.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06
Inst Owners66.31%
Inst Owner Change0%
Ins Owners4.41%
Ins Owner Change5.57%
Market Cap234.95M
Analysts83.08
Price Target16.49 (29.84%)
Short Float %9.21%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)86.9%
Min EPS beat(2)8.43%
Max EPS beat(2)165.36%
EPS beat(4)4
Avg EPS beat(4)98.79%
Min EPS beat(4)8.43%
Max EPS beat(4)165.36%
EPS beat(8)7
Avg EPS beat(8)87.09%
EPS beat(12)9
Avg EPS beat(12)59.89%
EPS beat(16)12
Avg EPS beat(16)46.49%
Revenue beat(2)2
Avg Revenue beat(2)9.71%
Min Revenue beat(2)4.37%
Max Revenue beat(2)15.05%
Revenue beat(4)2
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-16.43%
Max Revenue beat(4)15.05%
Revenue beat(8)5
Avg Revenue beat(8)0.01%
Revenue beat(12)6
Avg Revenue beat(12)-2.41%
Revenue beat(16)8
Avg Revenue beat(16)-1.16%
PT rev (1m)55.56%
PT rev (3m)66.42%
EPS NQ rev (1m)2.82%
EPS NQ rev (3m)179.98%
EPS NY rev (1m)32.65%
EPS NY rev (3m)39.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.07%
Valuation
Industry RankSector Rank
PE 24.42
Fwd PE 18.74
P/S 2.49
P/FCF 37.57
P/OCF 35.41
P/B 2.02
P/tB 262.51
EV/EBITDA 248.19
EPS(TTM)0.52
EY4.09%
EPS(NY)0.68
Fwd EY5.34%
FCF(TTM)0.34
FCFY2.66%
OCF(TTM)0.36
OCFY2.82%
SpS5.1
BVpS6.28
TBVpS0.05
PEG (NY)0.35
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA -9.18%
ROE -13.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.13%
FCFM 6.63%
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 5.2
Debt/EBITDA 27.69
Cap/Depr 8.75%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion 629.51%
Profit Quality N/A
Current Ratio 2.82
Quick Ratio 2.82
Altman-Z 2.88
F-Score6
WACC11.66%
ROIC/WACCN/A
Cap/Depr(3y)19.52%
Cap/Depr(5y)17.6%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.09%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%172.73%
EPS Next Y70.44%
EPS Next 2Y43.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.66%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%11.37%
Revenue Next Year14.64%
Revenue Next 2Y12.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year184.56%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.71%
FCF growth 3Y154.28%
FCF growth 5YN/A
OCF growth 1Y2.39%
OCF growth 3Y88.49%
OCF growth 5YN/A